Diazoxide toxicity with hypoglycemia in infants with trisomy 13

Pediatr Neonatol. 2021 Nov;62(6):679-680. doi: 10.1016/j.pedneo.2021.06.010. Epub 2021 Jul 24.

Authors

Mitsuhide Nagaoka¹, Mutsumi Akaishi², Kouichi Iida², Taketoshi Yoshida³

Affiliations

¹ Division of Neonatology, Maternal and Perinatal Center, Toyama University Hospital, Toyama, Japan.
² Department of Neonatology, Oita Prefectural Hospital, Oita, Japan.
³ Division of Neonatology, Maternal and Perinatal Center, Toyama University Hospital, Toyama, Japan. Electronic address: ytake@med.u-toyama.ac.jp.

PMID: 34417120
DOI: 10.1016/j.pedneo.2021.06.010

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Blood Glucose
Diazoxide* / adverse effects
Humans
Hypoglycemia* / chemically induced
Infant
Trisomy 13 Syndrome

Substances

Blood Glucose
Diazoxide